wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47788774-93CD6C19-6637-4965-8BA2-0437120DDF94
Q47788774-93CD6C19-6637-4965-8BA2-0437120DDF94
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47788774-93CD6C19-6637-4965-8BA2-0437120DDF94
Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results.
P2860
Q47788774-93CD6C19-6637-4965-8BA2-0437120DDF94
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47788774-93CD6C19-6637-4965-8BA2-0437120DDF94
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fd5183b2577e1c53d74ab152640539652f4744a3
P2860
BRCA1-like profile predicts benefit of tandem high dose epirubicin-cyclophospamide-thiotepa in high risk breast cancer patients randomized in the WSG-AM01 trial.